3 курс / Фармакология / Voinov_Efferentnaya_terapia_-_5_redaktsia

381

Avendano G.F., Agrawal R.K., Bashey R.I. et al. Effects of glucose intolerance on myocardial function and collagen-linked glycation // Diabetes. – 1999. – Vol. 48, № 7. – P. 1443-1447.

Baharav E., Merimski O., Shoenfeld Y. et al. Thyrosinase as an autoantigen in patients with vitiligo // Clin. Exp. Immunol. - 1996. - Vol. 105, № 1. - P. 84-88.

Baisch J.M., Weeks T., Giles R. et al. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus // N. Eng. J. Med. - 1990. - Vol. 322, № 24. - P. 1836-1841.

Balasch J., Creus M., Fabregues F. et al. Visible and non-visible еndometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study // Hum. Reprod. – 1996. – Vol. 11, № 3. – P. 387-391.

Baltazares M., Mendoza F., Dábaque J., Reyes P.A. Antiaorta antibodies and Takayasu arteritis // Int. J. Cardiol. - 1998. - Vol. 66, Suppl. 1. - P. 183-187.

Bambauer R., Schiel R., Latza R. Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies // Ther. Apher. – 2000. – Vol. 4, № 3. – P. 213-217.

Bamichas G., Natse T., Christidou F. et al. Pkfsma exchange in patients with toxic epidermal necrolysis // Ther. Apher. Dial. – 2002. – Vol. 6, № 3. – P. 225-228.

Barcat D., Constans J., Guérin V. Antiprothrombin autoantibodies and portal vein thrombosis without antiphospholipid antibodies // J. Rheumatol. – 1999. – Vol. 27, № 5.

– P. 941-945.

Barnabe V., Sinigaglia F. Molecular mimicry and T cell-mediated autoimmune disease // J. Exp. Med. - 1997. - Vol. 185, № 9. - P. 1529-1531.

Barr M.L., Meiser B.M., Eisen H.J. et al. Photopheresis for the prevention of rejection in cardiac transplantation // N. Engl. J. Med. – 1998. – Vol. 339, № 24. – P. 1744-1751.

Barsness G.W., Peterson E.D., Ohman E.M. et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angiplasty // Circulation. - 1997. - Vol. 96, № 8. - P. 2551-2556.

Bartlett R.H., Schreiner R.J., Lewis D.A. et al. Extracorporeal life support (ESLS) for ARDS // Chest. - 1996. - Vol. 110, № 4. - Suppl. - P. 59S.

Batocchi A.P., Evoli A., Di Schino C., Tonali P. Therapeutic apheresis in myasthenia gravis // Ther. Apher. – 2000. – Vol. 4, № 4. – P. 275-279.

Batstra M.R., Bruining G.J., Aanstoot H-J. Antibody screening in a population of children // Ann. Med. - 1997. - Vol. 29, № 5. - P. 453-460.

Baty V., Blain H., Saadi L. et al. Fatal myocardial infarction in an elderly woman with the severe ulcerative colitis: What is the role of steroids? // Am. J. Gastroenterol. - 1998. - Vol. 93, № 10. - P. 2000-2001.

382

Baur L.A., O’Connor J., Pan D.A., Storlien L.H. Relationship between maternal risk of insulin resistance and the child’s muscle membrane fatty acid composition // Diabetes. – 1999. – Vol. 48, № 1. – P. 112-116.

Bavdekar A., Yajnik C.S., Fall C.H.D. et al. Insulin resistance syndrome in 8-year- old indian children. Small at birth, big at 8 years, or both? // Diabetes. – 1999. – Vol. 48, № 12. – P. 2422-2429.

Baynes J.W., Thorpe S.R. Role of oxidative stress in diebetic complications. A new perspective on an old paradigm // Diabetes. – 1999. – Vol. 48, № 1. – P. 1-9.

Beeck H., Hellstern P. In vitro characterization of solvent / detergent-treated human plasma and a quarantine fresh frozen plasma // Vox Sang. - 1998. - Vol. 74, Suppl. 1. - P. 219-223.

Bell D.M. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview // Am. J. Med. - 1998. - Vol. 102, № 5B. - P. 9 - 15.

Bellentani S., Pozzato G., Saccoccio G. et al. Clinical course and risk factors of hepatitis C virus relevated liver disease in the general population: report from the Dionysos study // Gut. – 1999. – Vol. 44, № 6. – P. 874-880.

Belperio J.A., Weigt S.S., Fishbein M.C., Lynch J.P. Chronic lung allograft rejection: mechanisms and therapy // Proc. Am. Thorac. Soc. – 2009. – Vol. 6, № 1. – P. 108-121.

Ben David Y., Warner E., Levitan M. et al. Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis // Cancer. - 1996. - Vol. 78, № 10. - P. 2153-2156.

Bennett W.G., Inoue Y., Beck J.R. et al. Estimated of the cost-effectiveness of a single course of interferon-α2b in patients with histologically mild chronic hepatitis C // Ann. Intern. Med. - 1997. - Vol. 127, № 10. - P. - 855-865.

Benson M.D. Aging, amyloid, and cardiomyopathy // New Engl. J. Med. - 1997. - Vol. 336, № 7. - P. 502-504.

Bergasa N.V. Pruritus in primary biliary cirrhosis: pathogenesis and therapy // Clin. Liver. Dis. – 2008. – Vol. 12, № 2. – P. 385-406.

Berger A., Schrarer I., Doerr H.W. et al. Infection with hepatitis G virus in immunoglobulin recepients // Lancet. - 1997. - Vol. 349, № 9046. - P. 207.

Bernard C.C.A., Johns T.G., Slavin A. et al. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis // J. Mol. Med. - 1997. - Vol. 75, № 2. - P. 77-88.

Bernard G.R., Artigas A., Brigham K.L., Carlet J. et al. The American-European consensus conference on ARDS: definition, mechanisms, relevant outcomes, and clinical trial coordination // Am. J. Respir. Crit. Care Med. - 1994. - Vol. 149, № 9. - P. 818-824.

Berube C., Mitchell L., Silverman E. et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus

383

erythematosus: a cross-sectional studt // Pediatr. Res. – 1988. – Vol. 44, № 3. – P. 351356.

Betteridge D.J. LDL heterogenety: implications for atherogenicity in insulin resistence and NIDDM // Diabetologia. - 1997. - Vol. 40, Suppl. 2. - P. 149-151.

Beyreuther K., Masters C.L. The ins and outs of amyloid-β // Nature. - 1997. - Vol. 389, № 6652. - P. - 677-678/

Bianco A., Spiten M.A. Peripheral anergy and local immune hyperactivation in sarcoidosis: a paradox of birds of a feaver // Clin. Exp. Immunol. - 1997. - Vol. 110, № 1. - P. - 1-3.

Biasucci L.M., Liuzzo G., Fantuzzi G. et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalisation in unstable angina are associated with increased risk of in-hospital coronary events // Circulation. – 1999. – Vol. 99, № 16. – P. 2079-2084.

Biesenbach G., Grefinger P., Janko O., Zazgornik J. Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients // Clin. Nephrol. – 1997. – Vol. 48, № 3. – P. 146-150.

Billheden J., Boman J., Stegmayr B. et al. Glomerular basement membrane antibodies in hantavirus disease (hemorrhagic fever with renal syndrome) // Clin. Nephrol. – 1997. – Vol. 48, № 3. – P. 137-140.

Bingley P.J., Christie M.R., Bonifacio E et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives // Diabetes. - 1994. - Vol. 43, № 11. - P. 1304-1310.

Bingley P.J., Bonifacio E., Williams A.J.K. et al. Prediction of IDDM in the general population. Strategies based on combinations of autoantibody markers // Diabetes. - 1997. - Vol. 46, № 11. - P. - 1701-1711.

Birkenfeld A., Mukaida T. Incidence of autoimmune antibodies in failed embryo transfer cycles // Am. J. Reprod. Immunol. - 1994. - Vol. 31, № 1. - P. 65-68.

Bishoff S.C., Lorentz A., Schwengberg S. et al. Mast cells are an important cellular sourse of tumor necrosis factor α in human intestinal tissue // Gut. – 1999. – Vol. 44, № 5. – P. 643-652.

Bistrian B.R. Acute phase proteins and the systemic inflammatory response // Crit. Care Med. - 1999. - Vol. 27, № 3. - P. 452-453.

Bizollon T., Ducerf C., Trepo C. Hepatitis C virus recurrence after liver transplantation // Gut. – 1999. – Vol. 44, № 4. – P. 575-578.

Bjoro K., Haaland T., Skaug K., Froland S.S. The spectrum of hepatobiliary disease in primary hypogammaglobulinaemia // J. Intern. Med. – 1999. – Vol. 245, № 5. – P. 517-524.

Black A.J., McLeod H.L., Capell H.A. et al. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azayhioprine // Ann. Intern. Med. – 1998. – Vol. 129, № 9. - p. 716-718.

384

Bláha M. Extracorporeal LDL-cholesterol elimination in the treatment of severe familial hypercholesterolemia // Acta Medica (Hradec Kralove). – 2003. – Vol. 46, № 1.

– P. 3-7.

Blanas E., Carbone F.R., Allison J. et al. Induction of autoimmune diabetes by oral administration of autoantigen // Science. - 1966. - Vol. 274, № 5293. - P. 1707-1709.

Boers M., Verhoeven A., Markusse H.M. et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis // Lancet. - 1997. - Vol. 350, № 9074.- P. - 309-311.

Boker K.H.W., Manns M.P. Diagnosis and treatment of chronic hepatitis // Med. Klin. - 1995. - Vol. 90, № 7. - P. 411-423.

Bone R.C. Sir Isaac Newton, sepsis, SIRS, and CARS // Crit. Care Med. - 1996. - Vol. 24, № 7. - P. 1125-1128.

Bonnet D., de Lonlay P., Gautier I. Efficiency of metabolic screening in childhood cardiomyopathies // Eur. Heart J. – 1998. – Vol. 19, № 5. – P. 790-793.

Bosch T., Schmidt B., Blumenstein M., Gurland H.J. Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new lowdensity lipoproteins; adsorber compatible with human whole blood // Artif. Organs. – 1993. – Vol. 17. – P. 640-652.

Bosh T., Wendler T. State of the art of low-density lipoprotein apheresis in year 2003 // Ther. Apher. Dial. – 2004. – Vol. 8, № 2. – P. 76-79.

Bosch T. Therapeutic apheresis – state of the art in the year 2005 // Ther. Apher. Dial. – 2005. – Vol. 9, № 6. – P. 459-468.

Boumendil E.F. Mortality from non-cardiovascular disease and diabetes mellitus // Lancet. – 1998. – Vol. 351, № 9102. – P. 598-599.

Bouten M.J., Froon A.H., Gaillard C.A. et al. The systemic inflammatory response in the development of ventilator-associated pneumonia // Am. J. Respir. Crit. Care Med. - 1997. - Vol. 156, № 4 Pt 1. - P. - 1105-1113.

Bowman J.M. RhD hemolytic disease of the newborn // N. Engl. J. Med. – 1998. – Vol. 339, № 24. – P. 1775-1777.

Brashear H.R., Phillips L.H. Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome // Neurology. - 1991. - Vol. 41, № 10. - P. 15881592.

Brannagan Th.H., Nagle K.L., Lange D.J., Rowland L.P. Complications of intravenous immune globulin treatment in neurologic disease // Neurology. - 1996. - Vol. 47, № 3. - P. 674-677.

Brannagan T.H. Current treatments of chronic immune-mediated demyelinating polyneuropathies // Muscle Nerve. – 2009. – Vol. 39, № 5. – P. 563-578.

385

Brener Z., Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas’ disease // Int. Arch. Allergy Immunol. - 1997. - Vol. 114, № 2 . - P . 103-110.

Brimnes J., Halberg P., Jacobsen S. et al. Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA) // Clin. Exp. Immunol. - 1997. - Vol. 110, № 2. - P. 250-256.

Brito E.M., Barbosa A.J. Symptomatic eosinophilic esophagitis and esophageal candidiasis // Am. J. Gastroenterol. – 1998. – Vol. 93, № 10. – P. 2003-2004.

Brooks-Worrell B.M., Starkebaum G.A., Greenbaum C. et al. Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins // J. Immunol. - 1996. - Vol. 157, № 12. - P. 5668-5674.

Brooks-Worrell B.M., Juneja R., Minokadeh A. et al. Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients // Diabetes. - 1999. - Vol. 48, № 5. - P. 983-988.

Bruckert E., Baccara-Dinet M., Aschwege E. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidemia // Diabet. Med. – 2007. – V. 4, № 3. – P. 388-391.

Bruni R., Giannini G., Lercari G. et al. Cascade filtration for TTP: an effective alternative to plasma exchange with cryodepleted plasma // Transfus. Sci. – 1999. – Vol. 21, № 3. – P. 193-199.

Buchanan T.A., Xiang A.H., Kjos S.L. et al. Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes // Diabetes. – 1999. – Vol. 48, № 12. – P. 24302436.

Buckley C.D. Treatment of rheumatoid arthritis // B. M. J. - 1997. - Vol. 315, № 7102. - P. 236-238.

Burnouf T. New trends in plasma fractionation and plasma products trends in plasma fractionation // Vox Sang. – 1994. – Vol. 67, S. 3. – P. 251-253.

Busund R., Koukline V., Utrobin U., Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial // Int. Care Med. – 2002. – V. 28, № 10. – P. 1434-1439.

Caballero A.E., Arora S., Saouaf R. et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes //Diabetes. – 1999. – Vol. 48, № 9 .- P. 1856-1862.

Caforio A.L.P., Goldman J.H.,Haven A.J. et al. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives // Int. J. Cardiol. - 1996. - Vol. 54, № 2. - Р. 157-163.

Caldini P., Leith D., Brennan M.J. Effect of continuous positive-pressure ventilation (CPPV) on edema formation in dog lung // J. Appl. Physiol. - 1975. - Vol. 39, № 4. - P. 672-679.

386

Campion E.W. Desperate diseases and plasmapheresis // New Engl. J. Med. - 1992. - Vol. 326, № 6. - P. 1425-1427.

Campo N., Sinelli N., Brizzolara R. et al. Hepatitis G virus infection in haemodialysis and in peritoneal dialysis patients // Nephron. – 1999. – Vol. 82, № 1. – P. 17-21.

Cardella C. Plasma exachange and renal transplantation // J. Clin. Apheresis. – 1985. – Vol. 2, № 4. – P. 405-409.

Cardoso F. Sydenham”s Chorea // Curr. Treat. Options. Neurol. – 2008. – Vol. 10, № 3. – P. 230-235.

Carreras L.O., Forastiero R.R. Pathogenic role of antiprotein-phospholipid antibodies // Haemostasis. - 1996. - Vol. 26, Suppl. 4. - P. 340-357.

Castillo G., Ngo C., Cummings J. et al. Perlecan binds to the β-amyloid proteins (Aβ) of Alzheimer’s disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability // J. Neurochem. – 1997. – Vol. 69, № 6. – P. 2452-2465.

Cattral M.S., Hemming A.W., Wanless I.R. et al. Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation // Transplantation. – 1999. – Vol. 67, № 9. – P. 1277-1280.

Caudai C., Maimone D., Almi P. et al. The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C // Gut. - 1997. - Vol. 41, № 3. - P. - 411-412.

Celsi G., Kistner A., Aizman R. et al. Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in offspring // Pediatr. Res.

– 1998. – Vol. 44, № 3. – P. 317-322.

Chamarthi B., Dubrey S.W., Cha K. et al. Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis // Am. J. Cardiol. - 1997. - Vol. 80, № 9. - P. 1242-1245.

Chan L.S., Lapiere J.-Ch., Chen M. et al. Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen // Arch. Dermatol. – 1999. – Vol. 135, № 5. – P. 569-673.

Chanana B., Gupta N., Azad R.V. Case report: bilateral simultaneous central retinal vein occlusion in Waldenström’s macroglobulinemia // Optometry. – 2009. – Vol. 80, № 7. – P. 350-353.

Chen K.R., Carlson J.A. Clinical approach to cutaneous vasculitis // Am. J. Clin. Dermatol. – 2008. – Vol. 9., № 2. – P. 71-92.

Chen W.H., Chen C.J. Antiphospholipid antibody, head-shaking and ataxia: an evidence of non-vascular neurotoxicity and successful treatment by plasmapheresis // Rheumatol. Int. – 2009. – Vol. 29, № 7. – P. 827-829.

Cheng H.-M. Antiphospholipid antibodies, annexin V, and pregnancy loss // N. Eng. J. Med. - 1997. - Vol. 337, № 22. - P. 1630-1631.

387

Cherin P., Auperin I., Bussel A. et al. Plasma exchange in polymyositis and dermatomyositis: a multicenter study of 57 cases // Clin. Exp. Rheumatol. - 1995. - Vol. 13, № 2. - P. 270-271.

Chiang L.M., Darras B.T., Kang P.B. Juvenile myasthenia gravis // Muscle. Nerve. – 2009. – Vol. 39, № 4. – P. 423-431.

Chiu B., Viira E., Tucker W., Fong I.W. Chlamidia pneumoniae, Cytomegalovirus and Herpes simplex virus in atherosclerosis of the carotid artery // Circulation. - 1997. - Vol. 96, № 7. - P. - 2144-2148.

Christie J.M.L., Healey C.J., Watson J. et al. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up // Clin. Exp. Immunol. - 1997. - Vol. 110, № 1. - P. 0- 4-8.

Cianfarani S., Germani D., Rossi P. et al. Intrauterine growth retardation: evidence for the activation of the insulin-like growth factor (IGF) – related growth-promoting machinery and the presence of a cation-independent IGF binding protein-3 proteolytic activity by two months of life // Pediatr. Res. – 1998. – Vol. 44, № 3. – P. 374-380.

Clear D. Anaphylactoid reaction to metylprednisolone developing after treatment with interferon β-1b // J. Neurol. Neurosurd. Psychiatry. – 1999. - Vol. 166, № 5. - P. 690.

Cochat P., Kassir A., Colon S. et al. Recurrent nephrotic syndrome after transplantation: early treatment with plasmapheresis and cyclophosphamide // Pediat. Nephrol. - 1993, № 7. - P. 50-54.

Coker M., Ucar S.K., Simsek D.G. et al. Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia // Ther. Apher. Dial. – 2009. – Vol. 13, № 2. – P. 121-128.

Cole E., Cattran D., Magil A. et al. A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescendic glomerulonephritis // Am. J. Kidney Dis. – 1992. – Vol. 20. – P. 261-268.

Coman T., Dalloz M.A., Coolen N. et al. Plasmapheresis for the treatment of acute pancreatitis induced by hemophagocytic syndrome related to hypertriglyceridemia // J. Clin. Apher. – 2003. – Vol. 18, № 3. – P. 129-131.

Comoy E., Pestel J., Stewart G.A. et al. Do allergens induce type-2 immune responses? // Int. Arch. Allergy Immunol. – 1999. – Vol. 118, № 2-4. – P. 399-402.

Compston J.E. Management of bone disease in patients on long term glucocorticoig therapy // Gut. – 1999. – Vol. 44, № 6. – P. 770-772.

Connaughton M., Webber J. Diabetes and coronary artery disease: time to stop taking tablets // Heart. - 1998. - Vol. 80, № 2. - P. 108-109.

Cooper M.E., Vranes D., Youssef S. et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes // Diabetes. – 1999. – Vol. 48, № 11. – P. 2229-2239.

388

Coroneos E. et al. Fibrillary glomerulonephritis associated with hepatitis C viral infection // Amer. J. Kidney Dis. - 1997. - Vol. 29, № 1. - Р. 132-135.

Couper J.J., Steele C., Beresford S. et al. Lack of association between duration of breast-feeding on introduction of cow’s milk and development of islet autoimmunity // Diabetes. – 1999. – Vol. 48, № 11. – P. 2145-2149.

Covinsky K.E., Wu A.W., Landefeld C.S. et al. Health status versus quality of life in older patients: does the distinction matter? // Am. J. Med. – 1999. – Vol. 106, № 4. – P. 435-440.

Cox P.N., Frndova H., Tan P.S.K. et al. Concealed air leak associated with large tidal volumes in partial liquid ventilation // Am. J. Respir. Crit. Care Med. - 1997. - Vol. 156, № 3. - P. - 992-997.

Cowchock S. Autoantibodies and pregnancy loss // New. Eng. J. Med. - 1997. - Vol. 337, № 3. - P. 197-198.

Crieber B., Samain F., Vetter D. et al. Systematic cutaneous examination in hepatitis C virus infected patients // Acta Derm. Venerol. - 1998. - Vol. 78, № 5. - P. 355-357.

Crovato F., Rebora A. Chagas’ disease: a potential plaque for Europe? // Dermatology. - 1997. - Vol. 195, № 2. - P. - 184-185.

Cruzado J.M., de Córdoba S.R., MelilIi E. et al. Successful renal transplantation in a patient with atypical hemolytic syndrome carrying mutations in both factor I and MCP // Am. J. Transplant. – 2009. – Vol. 9, № 6.

Curb J.D., Rodriguez B.L., Abbott R.D. et al. Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance // Neurology. - 1999. - Vol. 52, 5. - P. - 971-975.

Churg A., Churg J. Steroids and Churg-Strauss syndrome // Lancet. - 1998. - Vol. 352, № 121. - P. 32-33.

Dada M.A., Kaplan A.A. Plasmapheres treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvement // Ther. Apher. Dial. – 2004. – Vol. 8, № 5. – P.409-412.

Dahlquist G. Hypothesis. Etiological aspects of insulin-dependent diabetes - an epidemiological perspective // Autoimmunity. - 1993. - Vol. 15, № 1. - P. 61-65.

Dahlquist G.G. Viruses and other perinatal exposures as initiating events for β-cell destruction // Ann. Med. - 1997. - Vol. 29, № 5. - Р. 413-417.

Dalakas M.C. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events // Neurology. - 1994. - Vol. 44, № 2. - P. 223-226.

Dalakas M.C. Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: present and future prospects // Ann. Neurol. - 1995. - Vol. 37, Suppl. 1. - P. S2-S13.

Dalakas M.C. Immunopathogenesis of inflammatory myopathies // Ann. Neurol. - 1995. - Vol. 37, Suppl. 1. - P. S74-86.

389

Datz C., Cramp M., Haas T. et al. The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre // Gut. – 1999. – Vol. 44, № 4. – P. 563-567.

Dau P.C., Denis E.H. Plasmapheresis and immunosupressive drug therapy in the Eaton-Lambert syndrome // Ann. Neurol. - 1982. - Vol. 11, № 6. - P. 570-575.

Daus H., Özbek C., Saage D. et al. Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation // Cardiology. – 1999. – Vol. 90, № 2. – P. 83-88.

Davis R.M., Wagner E.H., Groves T. Managing chronic disease // B. M. J. – 1999. – Vol. 318, № 7191. – P. 1090-1091.

Dechmann-Sultemeyer T., Linkeschova R., Lenztn K. et al. Tandem plasmapheresis and haemodialisis as a safe procedure in 82 patients with immune-mediated disease // Nephrol. Dial. Transplant. – 2009. – Vol. 24, № 1. – P. 252-257.

De Filippi F., Colombo M., Grazia Rumi M. et al. High rates of hepatitis G virus infection in multitransfused patients with hemophilia // Blood. - 1997. - Vol. 90, № 11. - P. 4634-4637.

Delaunay F., Khan A., Cintra A. et al. Pancreatic β cells are important targets for the diabetogenic effects of glucocorticoids // J. Clin. Invest. - 1997. - Vol. 100, 8. - P. - 2094-2098.

Delclaux C., Roupie E., Blot F. et al. Lower respiratory tract colonization and infection during severe adult respiratory distress syndrome // Am. J. Respir. Crit. Care Med. - 1997. - Vol. 156, № 4 Pt 1. - P. - 1092-1098.

De Leve L.D., Kaplowitz N. Prevention and therapy of drug-induced hepatic injury. – in: Therapy of digestive disorders . – W.B.Saunders Co, Philadelphia, 2000. – P. 334348.

Del Rosario M.L., Zucali J.R., Kao K.J. Prevention of graft-versus-host disease by induction of immune tolerance with ultraviolet B-irradiated leukocytes in H-2 disparate bone marrow donor // Blood. – 1999. – Vol. 93, № 10. – P. 3558-3564.

Demling R.H., Staub N.C., Edmunds L.H., Jr. Effect of end-expiratory airway pressure on accumulation of extravascular lung water // J. Appl. Physiol. - 1975. - Vol. 38, № 5. - P. 907-912.

Desai S.M., Muerhoff A.S., Leary T.P. et al. Prevalence of TT virus infection in US blood donors and population at risk for acquired parenterally transmitted viruses // J. Infect. Dis. – 1999. – Vol. 179, № 5. – P. 1242-1244.

Dick P.J., Low P.A., Windebank A.J. et al. Plasma exchange in polyneuropathy associated worth monoclonal gammapathy of undetermined significance // N. Eng. J. Med. - 1991. - Vol. 325, № 21. - P. 1482-1486.

Dick P.J., Litchy W.J., Kratz K.M. et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy // Ann. Neurol. - 1994. - Vol. 36, № 6. - P. 838-845.

390

Ding X., Aoki V, Mascaro J.M. et al. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles // J. Invest. Dermatol. - 1997. - Vol., 109, № 4. - P. 592-596.

D’Olhaberriaque L., Levine S.R., Salowich-Palm L. et al. Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS disseases // Neurology. – 1998. – Vol. 51, № 5. – P. 1376-1380.

Dondhi D., Schanz U., Sahrbacher U. et al. Life-threatening or organ-impairing Henoch-Schönlein purpura: plasmapheresis may save lives and limit organ damage // Dermatology. – 2009. - № 6.

Dörfel W.V., Felix S.B., Wallucat G. Et al. Short-term hemodinamic affects of immunoadsorption in dilated cardiomyopathy // Circulation. - 1997. - Vol. 95, № 8. - Р. 1994-1997.

Dörfel W.V., Wallikat G., Baumann G., Felix S.B. Immunoadsorption in dilated cardiomyopathy // Ther. Apher. – 2000. – Vol. 4, № 3. – P. – 235-238.

Dormann D., Montermann E., Klimek L. et al. Heterogeneity in the polyclonal T cell response to birch pollen allergens // Int. Arch. Allergy Immunol. - 1997. - Vol. 114, № 3. - p. - 272-277.

Dornhoffer L.L., Warner M., Arenberg I.K., Montegue D. Immunoperoxidase study of the endolymphatic sac in Ménièr’s disease // Laryngoscope. - 1993. - Vol. 103. - P. 1027-1034.

Dropcho E.J. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options // Ann. Neurol. - 1995. - Vol. 37, Suppl. 1. - P. S102-S113.

D’Sousa R.J., Kwan J.T.C. et al. Successful outcome of treating hemolitic uremic syndrome associated with cancer chemotherapy with immunoadsorption // Clin. Nephrol. - 1997. - Vol. 47, № 1. - P. 58-59.

Duh E., Aiello L.P. Vascular endothelial grows factor and diabetes. The agonist versus antagonist paradox // Diabetes. – 1999. Vol. 48, № 10. – P. 1899-1906.

Duhaut P., Berruyer M., Pinede L. et al. Anticardiolipin antibodies and giant cell arteritis. A prospective, multicenter case-control study // Arthritis Rheum. – 1998. – Vol.

41.– P. 701-709.

Durusoy Ç., Alpsoy E., Yilmaz E. Pitupiasis rosea in patient with Bechçet’s disease

treated with interferon alpha 2A // J. Dermatol. – 1999. – Vol. 26, № 4. – P. 225-228. Ebner C. Immunological mechanisms operative in allergen-specific immunotherapy

// Int. Arch. Allergy Immunol. – 1999. – Vol. 119, № 1. – P. 1-5.

Elies R., Ferrari I., Wallukat G. et al. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas’ disease // J. Immunol. – 1996. – Vol. 157, № 9. – P. 4203-4211.